Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization Required

— Improves Phexxi coverage for more than 5.8 million New York lives — — Year-to-date, Evofem has gained Phexxi coverage for more than 22.1 million new lives — SAN DIEGO, April 12, 2023 /PRNewswire/ — Evofem Biosciences, Inc., (OTCQB: EVFM) today announced a major new win in New York…